{"denoms":[{"counts":[{"groupId":"BG000","value":"231"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"331"}],"units":"Participants"}],"groups":[{"description":"Vandetanib (300 mg daily)","id":"BG000","title":"Vandetanib 300 mg"},{"description":"Placebo daily","id":"BG001","title":"Placebo"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"18","upperLimit":"83","value":"50.7"},{"groupId":"BG001","lowerLimit":"26","upperLimit":"84","value":"53.4"},{"groupId":"BG002","lowerLimit":"18","upperLimit":"84","value":"52"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"97"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"141"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"134"},{"groupId":"BG001","value":"56"},{"groupId":"BG002","value":"190"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}],"populationDescription":"The full analysis set included all randomized participants."}